AKT1 and rheumatoid arthritis: In RA, this pathway is aberrantly activated, and inhibiting the PI3K/AKT signal has been shown to decrease the production of pro-inflammatory mediators, increase the levels of anti-inflammatory cytokines, and alleviate synovial inflammation in RA patients.